Today’s Research Reports on Trending Tickers: AVEO Pharmaceuticals and Opko Health

NEW YORK, NY / ACCESSWIRE / January 17, 2017 / Early gains from the major indexes were erased Tuesday as political concerns weighed down the market’s recent rally. The Dow Jones Industrial Average declined 0.04 percent to close at 25,792.86, while the S&P 500 Index fell 0.35 percent to close at 2,776.42. The Nasdaq Composite Index dropped 0.51 percent to close at 7,223.69. All three major indexes have posted gains in the range of 22 percent to 30 percent over the past 12 months.

“We will see more market exuberance from positive earnings, but there is plenty of political uncertainty that will temper investor expectations,” said Alexandra Coupe, associate director and portfolio manager at PAAMCO.

RDI Initiates Coverage on:

AVEO Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=AVEO

Opko Health, Inc.
https://rdinvesting.com/news/?ticker=OPK

AVEO Pharmaceuticals stock moved 8.39% lower Tuesday, to close the day at $2.84. The stock recorded a trading volume of 4,235,042 shares, which was above its three months average volume of 1,826,280 shares. In the last year, AVEO Pharmaceuticals shares have traded in a range of 0.50 – 4.24. The share price has gained 468.00% from its 52 week low. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $2.90 is below its 200-day moving average of $3.07. Shares of AVEO Pharmaceuticals have fallen roughly 3.4 percent in the past month and are up 1.79 percent year-to-date.

Access RDI’s AVEO Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AVEO

On Tuesday, shares of Opko Health recorded a trading volume of 8,114,116 shares, which was above the three months average volume of 4,228,050 shares. The stock ended the day 7.63% lower at 4.60. The stock is currently trading 50.00% below its 52 week high with a 52 week trading range of 4.50 – 9.20. The company’s shares are currently trading below their 200-day moving average. The stock’s 50-day moving average of $5.03 is below its 200-day moving average of $5.99. Shares of Opko Health have fallen roughly 7.63 percent in the past month and are down 6.12 percent year-to-date.

Access RDI’s Opko Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OPK

Our Actionable Research on AVEO Pharmaceuticals, Inc. (NASDAQ :AVEO) and Opko Health, Inc. (NASDAQ :OPK) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 486231